VERI · Veritone, Inc. · Stock research

Current Thesis

The enterprise-AI growth story that carried this name to an $8.39 52-week high is broken on the numbers. On 2026-08-13 Veritone cut FY2026 revenue guidance from $130–145M to $100–115M against a $135.032M consensus — roughly a 23% reduction at the midpoint — and reported Q2 revenue of $24.263M versus $28.287M expected. What remains is a balance-sheet event: $45.6M of 1.75% convertible senior notes mature 2026-11-15 against $12.7M of cash and restricted cash at 2026-06-30, with management having disclosed substantial doubt about going-concern continuation. The narrative an investor would now be underwriting is not aiWARE adoption; it is whether the note gets exchanged, refinanced or converted on terms that leave the common equity with anything.

Life-cycle label: DEAD. The dating is the 2026-08-13 print — a guidance cut of that size with flat ARR ($62.0M) and bookings down 6.8% YoY is the growth thesis failing in public, and the -86.3% drawdown from the 52-week high is the structure confirming it. A refinancing outcome could produce a violent move in either direction; that is a binary on the capital structure, not a narrative regaining participation.

Bullish and bearish views on Veritone, Inc.

The model's bull view on Veritone, Inc. (VERI), in brief: Q2 FY2026 revenue $24.263M, +4.6% YoY from $23.2M and +20% sequentially (2026-08-13 release) — the sequential line is still rising even as the annual guide came down. The bear view: The FY2026 guide midpoint moved from ~$137.5M to ~$107.5M in one release (2026-08-13). Both cases follow in full.

Bull Case

• Q2 FY2026 revenue $24.263M, +4.6% YoY from $23.2M and +20% sequentially (2026-08-13 release) — the sequential line is still rising even as the annual guide came down.
• Adjusted EPS -$0.11 beat the -$0.12 consensus (2026-08-13) — the cost line is behaving better than the top line.
• ARR $62.0M at 2026-06-30, roughly flat YoY, with gross revenue retention above 90% (Q2 2026 release). The installed base is not churning out.
• $11.3M of annualized cost reductions completed in phase one, with $3.5–8.5M more targeted by year-end 2026; management put break-even in H1 FY2027 at $125–130M of annual revenue (2026-08-13 call).
• Management stated a public-sector pipeline above $200M and a near-term Veritone Data Refinery pipeline above $65M on the 2026-08-13 call, and attributed the Q2 shortfall to Department of Defense budget reallocation it expects to re-engage in H2 2026 or early 2027.
• ZeroEyes partnership announced 2026-08-12 — weapons detection and threat intelligence — extends the public-safety surface area.
• Needham maintained Buy and lowered its price target to $5 on 2026-08-14, roughly 4.3x the 2026-08-14 close of $1.15. That gap is an observable, and it is the sell-side's view, not a measured outcome.

Bear Case

• The FY2026 guide midpoint moved from ~$137.5M to ~$107.5M in one release (2026-08-13). The low end, $100M, sits $35M below the $135.032M consensus that existed the day before.
• Cash and restricted cash fell to $12.7M at 2026-06-30 from $27.7M at 2025-12-31 — $15.0M consumed in six months against a $45.6M principal obligation due 2026-11-15.
• Current ratio 0.52 at 2026-06-30 per call coverage; the converts sit in the current portion of the balance sheet at $45.5M.
• Going-concern doubt was disclosed in the FY2025 annual report and repeated in the Q1 FY2026 10-Q, tied specifically to the November 2026 maturity and recurring negative cash flow.
• New bookings of $13.9M in Q2 were down 6.8% YoY — demand softened at the same time revenue guidance came down, so the shortfall is not purely a recognition-timing artifact.
• Non-GAAP net loss widened to $10.0M from $8.4M a year earlier even as the GAAP loss narrowed to $22.2M from $26.5M.
• Gross margin guided to 60–65%, compressed by the lower-margin Veritone Data Refinery mix — the revenue that is growing carries less contribution.
• On debt, the CFO said only that discussions with holders are "active" with detail coming "in the upcoming weeks and months" (2026-08-13). No term sheet, no counterparty, no date.
• Inference, flagged as such: with $12.7M of cash against a $45.6M maturity three months out, any solution short of a full third-party refinancing implies equity issuance or conversion. Nothing in the 2026-08-13 disclosure quantifies dilution.

Setup & Price Structure

• Last completed daily close $1.15 on 2026-08-14; 52-week high $8.39; -86.3% from that high; -44.4% over three months.
• The regular session on 2026-08-13 closed at $1.49 before the print; shares fell ~23.5% after hours to roughly $1.14 (Investing.com earnings-call coverage, 2026-08-13). That $1.49 shelf is the level any recovery attempt has to reclaim.
• RSI(14) at 53.5 as of the 2026-08-14 close — mid-range. The name is deeply drawn down without registering a momentum washout, so "oversold bounce" is not what the oscillator is showing.
• $1.00 is the structural line. Nasdaq's minimum bid price rule requires a $1.00 bid; 30 consecutive business days below it produces a deficiency notice and a 180-day cure period. At $1.15 the clock has not started, and the buffer is 13%.
• Crowding and positioning observables, stated without a verdict: a maintained Buy with a $5 target published 2026-08-14 against a $1.15 close; no scheduled earnings inside the next 30 days to force a repricing; a disclosed funding gap of roughly $33M between cash on hand and the November principal; and a sub-$2 quote, which is the price band where retail-sentiment coverage tends to cluster. There is no insider transaction or issuance filing in the available record to cite here.

Catalyst Calendar (next 30 days)

• ~2026-09-30 (est.) — Unscheduled. Management guided on 2026-08-13 to providing restructuring detail within "weeks and months." Any 8-K announcing an exchange, refinancing or amendment lands without warning.
• Rolling, daily — Nasdaq bid-price observation. A first close below $1.00 starts a 30-business-day count, not an immediate notice.
• Nothing else is confirmed on the calendar inside the window. The anchoring dates sit outside it: 2026-11-15 (convertible maturity) and ~2026-11-12 (est.) (Q3 FY2026 print).

Elapsed catalysts

• ~2026-08-14 (est.) — Q2 FY2026 Form 10-Q. The going-concern footnote and the convertible-note disclosure are the checkable items; wording changes versus the Q1 filing are the signal. (passed 1d ago)

What Would Change Our Mind

The datapoint that reopens this name is a signed resolution of the $45.6M 1.75% converts — an exchange, a refinancing or a maturity extension — disclosed on an 8-K with terms that quantify the dilution rather than leave it open. Absent that, a second consecutive quarter of public-sector bookings recovery, with the Q3 print showing FY2026 revenue tracking at or above the $115M high end rather than the $100M low end, would argue the DoD delay was genuinely timing.

On price: a weekly close below $1.00 confirms the structural break, since it starts the Nasdaq deficiency clock and puts a reverse split — with all the supply mechanics that follow — on the table. On the other side, reclaiming and holding the pre-print $1.49 shelf on volume would be the first evidence the market is pricing a survivable capital structure. The 2026-11-15 maturity passing with the notes neither exchanged nor refinanced settles the question without needing a price level at all.

Correlation Notes

• Trades with the small-cap government-AI cohort (BigBear.ai, Palantir as the sentiment anchor) rather than with hyperscaler AI capex. The Q2 shortfall was attributed to Department of Defense budget reallocation, so defense-appropriations headlines drive it more than semiconductor or datacenter news.
• Shares below $2.00 on Nasdaq carry a shared factor that has nothing to do with the business: index-exclusion and delisting-risk flow, which moves the whole cohort on the same rule changes.
• The Veritone Data Refinery line is levered to AI training-data licensing demand, which correlates with model-lab procurement cycles and content-rights litigation outcomes — a separate driver from the public-safety and media software business.
• Idiosyncratic risk dominates through 2026-11-15. Until the convertible is resolved, capital-structure news should overwhelm sector beta in the day-to-day.